Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Universite Pierre et Marie Curie discloses DNA gyrase inhibitors

Jan. 8, 2016

U.S. Army starts phase I trial of dengue challenge virus

Jan. 8, 2016

Vical's VL-2397 wins FDA orphan drug designation for invasive aspergillosis

Jan. 7, 2016

Inovio reports results from phase IIb trial of VGX-3100 in cervical intraepithelial neoplasia

Jan. 7, 2016

VenatoRx Pharmaceuticals presents beta-lactamase inhibitors

Jan. 7, 2016

FDA grants priority review to Gilead's NDA for sofosbuvir/velpatasvir

Jan. 5, 2016

Yisheng Biopharma releases phase I topline results for PIKA rabies vaccine

Jan. 5, 2016

Matinas BioPharma files IND application with FDA for MAT-2501

Jan. 5, 2016

Arbutus initiates phase IIa study of ARB-001467 for chronic HBV

Jan. 5, 2016

Gilead Sciences studies ledipasvir/sofosbuvir for chronic HCV and HBV coinfection

Jan. 4, 2016

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...